Stryker Japan Unveils AlphaVent Biocomposite Suture Anchor
In a significant advancement for shoulder surgery, Stryker Japan has announced the upcoming launch of the
AlphaVent Biocomposite Suture Anchor. Set to hit the orthopedic market nationwide in January 2026, this new product aims to enhance the repair procedures for rotator cuff tears, which are prevalent among individuals due to aging, sports injury, or falls.
Understanding Rotator Cuff Tears
Rotator cuff tears occur when the shoulder muscles, known as the rotator cuff, partially detach from the bone, causing the fibers to rupture repeatedly. In Japan, an estimated
24,000 shoulder cuff repair surgeries are performed annually, highlighting the need for effective surgical solutions. The AlphaVent Biocomposite Suture Anchor features a unique design that allows for enhanced fixation of the torn rotator cuff to the humerus, facilitating a more effective recovery.
Advanced Design and Material
The product comprises an anchor and sutures, with three different sizes (4.75mm, 5.5mm, and 6.5mm) available to suit various procedures and patient anatomical needs. The AlphaVent anchor employs a
dual-thread technology that optimally grips both the cortical and cancellous bone during insertion, ensuring superior stability and ease of manipulation for surgeons.
Additionally, the anchor incorporates a biocomposite material made of
poly-L-lactic acid (PLLA) and
beta-tricalcium phosphate (β-TCP), both known for their compatibility with bone and a gradual absorption rate that enhances postoperative stability.
Expanding Treatment Options
The introduction of the Biocomposite type to Stryker’s portfolio adds a new dimension to their shoulder repair solutions, complementing existing products like the All-Suture ICONIX series and the non-absorbable AlphaVent PEEK anchors. Together, these innovations provide a diverse range of options for treating rotator cuff injuries.
Future Innovations
Alongside the launch of the AlphaVent Biocomposite Suture Anchor, Stryker Japan is also set to release the
1788 4K Camera System in 2024. This advanced imaging technology is designed for various arthroscopic surgeries of the shoulder and knee, providing surgeons with clear imagery that enhances surgical precision.
Stryker Japan's commitment to the sports medicine field is evident in its focus on developing total solution products, including suture anchors and advanced imaging devices. The goal is to continuously improve healthcare outcomes by providing innovative medical technologies that cater to both surgeons and patients.
About Stryker Japan
Stryker Japan, a subsidiary of Stryker Corporation based in Michigan, USA, is a global leader in medical technology. The company collaborates with healthcare professionals to push the boundaries of medical innovation, offering a wide range of cutting-edge medical devices and services, from orthopedic and spine-related fields to neurotechnology. Every year, Stryker affects change in over
150 million patients globally through its innovative solutions.
For more information, visit
Stryker Japan's website.
Manufacturer: Stryker Japan Co., Ltd.
Product Name: AlphaVent Biocomposite Suture Anchor
Medical Device Approval Number: 30700BZX00242000
Product Name: 1788 4K Camera System
Medical Device Notification Number: 13B1X10209001008